Seven Editora eBooks,
Journal Year:
2023,
Volume and Issue:
unknown
Published: May 12, 2023
According
to
the
WHO,
as
of
July
26,
2022,
there
were
568,773,510
confirmed
cases
COVID-19
and
6,381,643
deaths
recorded
because
this
disease
worldwide
(WHO,
2022).
The
etiologic
agent
is
SARS-CoV-2
coronavirus,
an
RNA
virus
family
Coronaviridae
subfamily
Orthocoronavirinae
(XAVIER
et
al.,
2020).
Humans
infected
with
have
clinical
signs
such
fever,
non-productive
cough,
shortness
breath,
may
progress
pneumonia,
acute
respiratory
syndrome,
kidney
failure,
although
a
few
other
signs,
symptoms,
forms
be
observed
less
frequently
(SAXENA
evolution
infection
severe
syndrome
can
lead
death
from
COVID-19.
These
patients
strong
inflammatory
response,
like
that
cytokine
release
increased
migration
neutrophils
lung
tissue
triggered
by
mediators
released
epithelial,
endothelial
cells
immune
system
attracted
site
(MANGIAVACCHI
2020;
MERAD
al.
2022;
BHARDWAJ
LI
&
LI,
Veterinary World,
Journal Year:
2023,
Volume and Issue:
unknown, P. 1193 - 1200
Published: June 1, 2023
Coronaviruses
(members
of
the
Coronaviridae
family)
are
prominent
in
veterinary
medicine,
with
several
known
infectious
agents
commonly
reported.
In
contrast,
human
medicine
has
disregarded
coronaviruses
for
an
extended
period.
Within
past
two
decades,
have
caused
three
major
outbreaks.
One
such
outbreak
was
coronavirus
disease
2019
(COVID-19)
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2).
Over
3-year
COVID-19
outbreak,
instances
zooanthroponosis
been
documented,
which
pose
risks
virus
modifications
and
possible
re-emergence
into
population,
causing
a
new
epidemic
threats
vaccination
or
treatment
failure.
Therefore,
widespread
screening
animals
is
essential
technique
mitigating
future
repercussions.
However,
mass
detection
SARS-CoV-2
wild
might
be
challenging.
silico
prediction
modeling,
experimental
studies
conducted
on
various
animal
species,
natural
infection
episodes
recorded
species
provide
information
potential
to
wildlife.
They
may
useful
diagnostic
purposes.
this
review,
methods
wildlife
screening,
based
data
environmental
elements
that
play
crucial
role
its
effective
implementation,
reviewed.
Keywords:
angiotensin-converting
enzyme
2,
animals,
coronavirus-2,
surveillance.
Comparative Medicine,
Journal Year:
2021,
Volume and Issue:
71(5), P. 369 - 382
Published: Oct. 1, 2021
Since
the
World
Health
Organization
declared
COVID-19
a
pandemic
in
March
2020,
millions
of
people
have
contracted
SARS-CoV-2
and
died
from
infection.
Several
domestic
wild
species
disease
as
well.
From
beginning,
scientists
been
working
to
develop
vaccines
establish
therapies
that
can
prevent
development
improve
clinical
outcome
infected
people.
To
understand
various
aspects
viral
pathogenesis
infection
dynamics
support
preclinical
evaluation
therapeutics,
diverse
number
animal
evaluated
for
use
models
humans.
Here,
we
discuss
natural
captive
animals,
well
susceptibility
several
experimental
with
this
virus.
Viruses,
Journal Year:
2022,
Volume and Issue:
14(11), P. 2473 - 2473
Published: Nov. 9, 2022
The
coronavirus
disease
2019
(COVID-19)
pandemic
has
become
the
most
far-reaching
public
health
crisis
of
modern
times.
Several
efforts
are
underway
to
unravel
its
root
cause
as
well
proffer
adequate
preventive
or
inhibitive
measures.
Zoonotic
spillover
causative
virus
from
an
animal
reservoir
human
population
is
being
studied
likely
event
leading
pandemic.
Consequently,
it
important
consider
viral
evolution
and
process
spread
within
zoonotic
anthropogenic
transmission
cycles
a
global
impact.
diverse
routes
interspecies
SARS-CoV-2
offer
great
potential
for
future
viruses
evolving
current
circulation.
To
mitigate
possible
infectious
outbreaks
in
Africa
elsewhere,
there
urgent
need
surveillance,
prevention,
control
measures
that
must
include
focus
on
known
novel
emerging
pathogens
through
one
approach.
Human
immunization
should
be
approached
equally
transfer
cutting-edge
technology
vaccine
manufacturing
throughout
world
ensure
health.
Seven Editora eBooks,
Journal Year:
2023,
Volume and Issue:
unknown
Published: May 12, 2023
According
to
the
WHO,
as
of
July
26,
2022,
there
were
568,773,510
confirmed
cases
COVID-19
and
6,381,643
deaths
recorded
because
this
disease
worldwide
(WHO,
2022).
The
etiologic
agent
is
SARS-CoV-2
coronavirus,
an
RNA
virus
family
Coronaviridae
subfamily
Orthocoronavirinae
(XAVIER
et
al.,
2020).
Humans
infected
with
have
clinical
signs
such
fever,
non-productive
cough,
shortness
breath,
may
progress
pneumonia,
acute
respiratory
syndrome,
kidney
failure,
although
a
few
other
signs,
symptoms,
forms
be
observed
less
frequently
(SAXENA
evolution
infection
severe
syndrome
can
lead
death
from
COVID-19.
These
patients
strong
inflammatory
response,
like
that
cytokine
release
increased
migration
neutrophils
lung
tissue
triggered
by
mediators
released
epithelial,
endothelial
cells
immune
system
attracted
site
(MANGIAVACCHI
2020;
MERAD
al.
2022;
BHARDWAJ
LI
&
LI,
